SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-036754
Filing Date
2022-06-14
Accepted
2022-06-14 17:09:09
Documents
2
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1534
2 POA DOCUMENT poa.txt EX-24 4745
  Complete submission text file 0001209191-22-036754.txt   7637
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (206) 737-0085
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404
Business Address
Wassil Jim (Reporting) CIK: 0001813798 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40655 | Film No.: 221015687